Carregant...
RTHP-17. IDH GENE MUTATION STATUS PLAYS NO IMPACT ON SURVIVAL IN PATIENTS WITH GLIOBLASTOMA AT A FIRST PROGRESSION
BACKGROUND: Mutation in the isocitrate dehydrogenase (IDH) gene has established as a favorable prognostic factor for newly diagnosed glioblastoma (GBM). However, there have been few reports assessing whether the mutation is a prognostic factor for recurrent GBM. In the present study, we examined ove...
Guardat en:
| Publicat a: | Neuro Oncol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692789/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.901 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|